[PHARMA] QoQ Cumulative Quarter Result on 30-Jun-2015 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Jun-2015 [#2]
Profit Trend
QoQ- 51.01%
YoY- 13.79%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Revenue 559,195 2,189,312 1,509,162 984,749 471,904 2,122,933 1,495,830 -48.07%
PBT 26,538 112,722 89,005 63,668 38,612 125,580 87,726 -54.90%
Tax -8,068 -28,138 -20,462 -15,100 -6,686 -31,355 -30,122 -58.41%
NP 18,470 84,584 68,543 48,568 31,926 94,225 57,604 -53.12%
-
NP to SH 18,379 84,044 67,982 48,011 31,794 93,844 57,147 -53.02%
-
Tax Rate 30.40% 24.96% 22.99% 23.72% 17.32% 24.97% 34.34% -
Total Cost 540,725 2,104,728 1,440,619 936,181 439,978 2,028,708 1,438,226 -47.87%
-
Net Worth 515,906 529,482 534,070 527,991 528,173 525,526 507,513 1.09%
Dividend
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Div 10,354 77,674 59,542 36,234 18,123 72,486 41,429 -60.28%
Div Payout % 56.34% 92.42% 87.59% 75.47% 57.00% 77.24% 72.50% -
Equity
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Net Worth 515,906 529,482 534,070 527,991 528,173 525,526 507,513 1.09%
NOSH 258,859 258,915 258,880 258,819 258,908 258,880 258,935 -0.01%
Ratio Analysis
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
NP Margin 3.30% 3.86% 4.54% 4.93% 6.77% 4.44% 3.85% -
ROE 3.56% 15.87% 12.73% 9.09% 6.02% 17.86% 11.26% -
Per Share
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 216.02 845.57 582.96 380.48 182.27 820.05 577.69 -48.06%
EPS 7.10 32.46 26.26 18.55 12.28 36.25 22.07 -53.01%
DPS 4.00 30.00 23.00 14.00 7.00 28.00 16.00 -60.28%
NAPS 1.993 2.045 2.063 2.04 2.04 2.03 1.96 1.11%
Adjusted Per Share Value based on latest NOSH - 259,057
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 38.80 151.91 104.71 68.33 32.74 147.30 103.79 -48.07%
EPS 1.28 5.83 4.72 3.33 2.21 6.51 3.97 -52.94%
DPS 0.72 5.39 4.13 2.51 1.26 5.03 2.87 -60.18%
NAPS 0.358 0.3674 0.3706 0.3663 0.3665 0.3646 0.3521 1.11%
Price Multiplier on Financial Quarter End Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 -
Price 5.76 6.36 6.50 7.13 6.00 4.58 4.63 -
P/RPS 2.67 0.75 1.12 1.87 3.29 0.56 0.80 123.16%
P/EPS 81.13 19.59 24.75 38.44 48.86 12.63 20.98 146.16%
EY 1.23 5.10 4.04 2.60 2.05 7.91 4.77 -59.45%
DY 0.69 4.72 3.54 1.96 1.17 6.11 3.46 -65.83%
P/NAPS 2.89 3.11 3.15 3.50 2.94 2.26 2.36 14.44%
Price Multiplier on Announcement Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 13/05/16 15/02/16 26/11/15 17/08/15 18/05/15 23/02/15 21/11/14 -
Price 5.60 6.19 6.50 5.65 6.91 5.28 4.45 -
P/RPS 2.59 0.73 1.12 1.48 3.79 0.64 0.77 124.32%
P/EPS 78.87 19.07 24.75 30.46 56.27 14.57 20.16 148.07%
EY 1.27 5.24 4.04 3.28 1.78 6.87 4.96 -59.64%
DY 0.71 4.85 3.54 2.48 1.01 5.30 3.60 -66.08%
P/NAPS 2.81 3.03 3.15 2.77 3.39 2.60 2.27 15.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment